header
Image from OpenLibrary

The role of intraperitoneal chemotherapy in treatment of primary and recurrent epithelial ovarian carcinoma / Rasha Salama Mohammed ; Supervised Kamal Elghamrawy , Farouk Ahmed Hagag , Osama Taha

By: Contributor(s): Material type: TextTextLanguage: English Publication details: Cairo : Rasha Salama Mohammed , 2009Description: 126 P. : charts ; 25cmOther title:
  • دراسة عن دور حقن العلاج الكيمائيي داخل الغشاء البريتونى في المرضى الذين يعانون من الاورام الأولية و المرتجعة لغشاء المبيض [Added title page title]
Subject(s): Available additional physical forms:
  • Issued also as CD
Dissertation note: Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Oncology-Clinical Summary: A combination of IV and IP administration of chemotherapy conveys a significant survival benefit among womem with optimally debulked epithelial ovarian cancer, compared to IV administration alone. The three largest studies with the greatest survival advantage delivered cisplatin 100 mg/m² IP. , the chemotherapy regimens mandated modification based on patiem tolerance
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Home library Call number Copy number Status Date due Barcode
Thesis Thesis قاعة الرسائل الجامعية - الدور الاول المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.11.23.M.Sc.2009.Ra.R (Browse shelf(Opens below)) Not for loan 01010110052896000
CD - Rom CD - Rom مخـــزن الرســائل الجـــامعية - البدروم المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.11.23.M.Sc.2009.Ra.R (Browse shelf(Opens below)) 52896.CD Not for loan 01020110052896000

Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Oncology-Clinical

A combination of IV and IP administration of chemotherapy conveys a significant survival benefit among womem with optimally debulked epithelial ovarian cancer, compared to IV administration alone. The three largest studies with the greatest survival advantage delivered cisplatin 100 mg/m² IP. , the chemotherapy regimens mandated modification based on patiem tolerance

Issued also as CD

There are no comments on this title.

to post a comment.